Intrinsic Value of S&P & Nasdaq Contact Us

AgeX Therapeutics, Inc. AGE NYSE

NYSE • Healthcare • Biotechnology • US • USD

SharesGrow Score
24/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

AgeX Therapeutics, Inc. (AGE) has 15 known insider and institutional holders on record. The largest holder is Juvenescence US Corp. with 16,447,500 shares. Other notable holders include Juvenescence Ltd and MALIK NAFEES NASEER.

AGE Insider Ownership

Top Holder
Juvenescence US Corp.
16,447,500 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Juvenescence Us Corp. 10 Percent Owner 16,447,500 2023-03-22
100%
2 Juvenescence Ltd 10 Percent Owner 756,429 2023-05-18
5%
3 Malik Nafees Naseer Chief Operating Officer 75,000 2021-06-08
0%
4 Park Andrea Eun Jae Chief Financial Officer 75,000 2021-06-08
0%
5 Mulroy Michael H. Director 65,000 2019-03-13
0%
6 Jenkins Annalisa Director 65,000 2021-06-23
0%
7 Bailey Gregory Director 65,000 2021-06-23
0%
8 Hackett Joanne M. Director 65,000 2022-02-04
0%
9 Mauldin John F Director 65,000 2019-03-13
0%
10 May Michael H Director 35,000 2021-06-23
0%
11 Escarra Vicki B Director 5,373 2007-10-03
0%
12 Sternberg Hal Vice President-research 5,000 2021-06-08
0%
13 West Michael D Chief Executive Officer 3,125 2022-12-13
0%
14 Segall Judith Director of Admin & Secretary 3,000 2021-06-08
0%
15 Skibsted Russell Chief Financial Officer 935 2019-02-14
0%

No ownership data available for AGE.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message